Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1
Gönen et al.,
Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2)..,
Nutrients, doi:10.3390/nu13114047
Retrospective 867 hospitalized COVID-19 patients in Turkey, showing worse outcomes with vitamin D deficiency (without statistical significance); followed by a prospective study of 210 patients with vitamin D supplementation for those that were deficient, showing significantly lower mortality compared to the retrospective study without treatment.
risk of death, 65.8% lower, RR 0.34, p = 0.62, high D levels (≥12ng/mL) 1 of 80 (1.2%), low D levels (<12ng/mL) 3 of 82 (3.7%), NNT 42, retrospective study.
|
risk of ICU admission, 16.9% lower, RR 0.83, p = 1.00, high D levels (≥12ng/mL) 4 of 77 (5.2%), low D levels (<12ng/mL) 5 of 80 (6.2%), NNT 95, retrospective study.
|
hospital stay >8 days, 21.1% lower, RR 0.79, p = 0.11, high D levels (≥12ng/mL) 40 of 78 (51.3%), low D levels (<12ng/mL) 52 of 80 (65.0%), NNT 7.3, retrospective study.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Gönen et al., 12 Nov 2021, retrospective, Turkey, peer-reviewed, 20 authors, dosage varies.
Contact:
karraspiros@yahoo.gr, duygugezenak@iuc.edu.tr, duygugezenak@gmail.com, erdinc.dursun@iuc.edu.tr, erdincdu@gmail.com.
Abstract: nutrients
Article
Rapid and Effective Vitamin D Supplementation May Present
Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients
by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37,
and ICAM1
Mustafa Sait Gönen 1 , Merve Alaylıoğlu 2 , Emre Durcan 1 , Yusuf Özdemir 3 , Serdar Şahin 1 , Dildar Konukoğlu 4 ,
Okan Kadir Nohut 5 , Seval Ürkmez 6 , Berna Küçükece 7 , İlker İnanç Balkan 3 , H. Volkan Kara 8 ,
Şermin Börekçi 9 , Hande Özkaya 1 , Zekayi Kutlubay 10 , Yalım Dikmen 6 , Yılmaz Keskindemirci 11,12 ,
Spyridon N. Karras 13, * , Cedric Annweiler 14,15 , Duygu Gezen-Ak 2, * and Erdinç Dursun 2,16, *
1
2
3
Citation: Gönen, M.S.; Alaylıoğlu,
M.; Durcan, E.; Özdemir, Y.; Şahin, S.;
4
Konukoğlu, D.; Nohut, O.K.; Ürkmez,
S.; Küçükece, B.; Balkan, İ.İ.; et al.
5
Rapid and Effective Vitamin D
Supplementation May Present Better
6
Clinical Outcomes in COVID-19
(SARS-CoV-2) Patients by Altering
Serum INOS1, IL1B, IFNg,
Cathelicidin-LL37, and ICAM1.
7
8
Nutrients 2021, 13, 4047. https://
doi.org/10.3390/nu13114047
9
Academic Editors: Maria
10
Luz Fernandez, Andrea Fabbri and
Sara Gandini
Received: 15 September 2021
Accepted: 11 November 2021
Published: 12 November 2021
Publisher’s Note: MDPI stays neutral
11
12
13
14
15
with regard to jurisdictional claims in
published maps and institutional affil-
16
iations.
*
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
Endocrinology and Metabolism Unit, Department of Internal Medicine, Cerrahpasa Faculty of Medicine,
Istanbul University-Cerrahpasa, Istanbul 34098, Turkey; sait.gonen@iuc.edu.tr (M.S.G.);
dr.durcan@hotmail.com (E.D.); srdr_shn@hotmail.com (S.Ş.); hmba@iuc.edu.tr (H.Ö.)
Brain and Neurodegenerative Disorders Research Laboratories, Department of Medical Biology, Cerrahpasa
Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey; merve.alaylioglu@hotmail.com
Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul
University-Cerrahpasa, Istanbul 34098, Turkey; ozdemiryusufemre1990@gmail.com (Y.Ö.);
ilkerinancbalkan@hotmail.com (İ.İ.B.)
Department of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; dkonuk@istanbul.edu.tr
Fikert Biyal Biochemistry Laboratory, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; okannohut@hotmail.com
Department of Anesthesiology and Reanimation, Cerrahpasa Faculty of Medicine, Istanbul
University-Cerrahpasa, Istanbul 34098, Turkey; seval.urkmez@istanbul.edu.tr (S.Ü.);
ydikmen@iuc.edu.tr (Y.D.)
Cerrahpasa Hospital Pharmacy Unit, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; bernakucukece11@gmail.com
Department of Thoracic Surgery, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; volkan_kara@yahoo.com
Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; borekcisermin@gmail.com
Dermatology and Venerology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa,
Istanbul 34098, Turkey; zekayikutlubay@hotmail.com
General Directorate of Hospitals, Istanbul University-Cerrahpasa, Istanbul..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit